Bay Street News, 2020

Inhibigens (inhibitory antigens) are detrimental an otherwise protective immunotherapyInhibigens alter the tumor microenvironment and drive tumor hyperprogressionInhibigens abolish both [...]

SOUTH SAN FRANCISCO, Calif., June 22, 2020 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company […]

EMERYVILLE, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and […]

Rockville, MD, June 22, 2020 (GLOBE NEWSWIRE) —MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing […]

NEW YORK, June 22, 2020 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced preclinical data presentation for TG-1701, […]

CHARLOTTE, N.C., June 22, 2020 (GLOBE NEWSWIRE) — LPL Financial LLC, a leading retail investment advisory firm and independent broker-dealer, […]

Preclinical data presented at the American Association for Cancer Research 2020 Virtual Annual Meeting IIOngoing Phase 1b/2 clinical trial on […]

TNX-1700 (Stabilized Recombinant Trefoil Factor 2) (rTFF2-CTP) Enhances Anti-tumor Activity of PD-1blockade in Mouse Models of Colorectal CancerNEW YORK, June […]

Data demonstrate the ablation of solid tumors with nitric oxideAll tumor-bearing mice treated with nitric oxide rejected a second tumor […]

VANCOUVER, British Columbia, June 22, 2020 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; OTCQX: RIOFF; BVL: […]